Manulife (Manufacturers Life Insurance)
OCRX

Manulife (Manufacturers Life Insurance)’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,673
Closed -$2K – 4452
2017
Q2 		$2K Sell
1,673
-82
-5% -$95 ﹤0.01% 4173
2017
Q1 		$2K Hold
1,755
– – ﹤0.01% 3990
2016
Q4 		$4K Hold
1,755
– – ﹤0.01% 4012
2016
Q3 		$5K Hold
1,755
– – ﹤0.01% 3906
2016
Q2 		$3K Hold
1,755
– – ﹤0.01% 3968
2016
Q1 		$5K Hold
1,755
– – ﹤0.01% 3815
2015
Q4 		$5 Hold
1,755
– – ﹤0.01% 3681
2015
Q3 		$6 Hold
1,755
– – ﹤0.01% 3663
2015
Q2 		$7 Buy
1,755
+1,520
+647% +$5.83K ﹤0.01% 3638
2015
Q1 		$1 Hold
235
– – ﹤0.01% 3943
2014
Q4 		$2 Buy
+235
New +$1.38K ﹤0.01% 3781

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OCRX Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2017, closing a stake of 1,673 shares — an estimated $2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OCRX in Q4 2014 and held it in 11 quarters. The position peaked at $5K in Q3 2016. 21 funds tracked by Wall St. Rank hold OCRX as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Ocera Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,673 Ocera Therapeutics, Inc. shares in Q3 2017, an estimated $2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 11 quarters.
  • Manulife (Manufacturers Life Insurance)'s Ocera Therapeutics, Inc. position peaked at $5K in Q3 2016.
  • 21 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.